<DOC>
	<DOC>NCT00593762</DOC>
	<brief_summary>The purpose of the study is to determine the response to aspirin (ASA) and Clopidogrel in patients with peripheral arterial occlusive disease (PAOD) requiring interventional procedures and to investigate if patients with "resistance" to ASA or Clopidogrel have an unfavourable outcome during long-term follow-up</brief_summary>
	<brief_title>ASA- and Clopidogrel-Responsiveness in Patients With Peripheral Arterial Occlusive Disease and Interventional Procedures</brief_title>
	<detailed_description />
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>PAOD patients Age 1885 years Need for a catheter interventional procedure Antithrombotic therapy with aspirin or clopidogrel Comedication additionally compromising platelet function Known bleeding disorder Life expectancy &lt; 6 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Peripheral arterial occlusive disease</keyword>
	<keyword>Aspirin</keyword>
	<keyword>Clopidogrel</keyword>
	<keyword>Resistance</keyword>
	<keyword>Catheter interventional procedure</keyword>
	<keyword>ASA and clopidogrel resistance</keyword>
</DOC>